This week, we’re sharing the most recent top stories in psychiatry news. We have positive news on research of how semaglutide is being studied for weight loss, and as well as an article about oral ketamine on patients with depression. Research also indicates how simple exercise can be effective for sleep amongst the elderly, and how high fiber intake can lower depression risk in young women.
Read these stories and more below.
Clozapine Still Underused in Refractory Schizophrenia Medscape, February 12, 2021
Clozapine is not just the most effective antipsychotic for patients who are treatment resistant; it’s also the most effective antipsychotic in general populations,” said Marder, the Daniel X. Freedman Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles.
Semaglutide for Weight Loss? A Good First STEP, With Caveats Medscape, February 10th, 2021
There has been some buzz in the medical community of diabetes medication, semaglutide, to be used for weight loss. Although there is still more research to be done, the finding shows very promising results. And “unlike some previous appetite suppressant drugs which caused significant psychological and psychiatric side effects, there is no evidence that semaglutide has any adverse effects of that nature,” O’Rahilly noted.
Tai chi may improve sleep among older adults Healio, February 16, 2021
Both conventional exercise and tai chi were associated with modest sleep improvements, which were sustained for 24 months, according to results of a randomized clinical trial published in JAMA Network Open.
Higher dietary fiber tied to lower depression risk in young women MDedge, February 4, 2021
Higher fiber intake may be associated with decreased risk of depression in premenopausal women, new research suggests.Investigators analyzed data from close to 6,000 pre- and postmenopausal women. They found that, in premenopausal women, dietary fiber intake was higher among those without depression versus their counterparts with the disorder in a dose-dependent manner.
Oral ketamine experiment reduces suicidal thoughts in over two-thirds of patients ScienceAlert Latest, February 9, 2021
In recent years, ketamines’s reputation has undergone a makeover of sorts, thanks to new scientific discoveries of the positive effects it can have on people experiencing mental health issues. A wealth of research has shown that ketamine seems to be capable of treating severe depression, among other conditions. While the mysterious mechanisms behind these effects are still being explored, the FDA approved a ketamine-based nasal spray for depression in 2019.